C137H151N37O10 — CID 164953594
2-[[4-[1-[(6-tert-butyl-2-pyridinyl)methyl]triazol-4-yl]-6-(3-methylphenyl)-2-pyridinyl]amino]acetic acid;bis(carbon dioxide);(2S)-1-[6-[[4-[2-(cyclopropylamino)-6-(3-methylphenyl)pyrimidin-4-yl]triazol-1-yl]methyl]-2-pyridinyl]pyrrolidine-2-carboxylic acid;6-(3-methylphenyl)-4-[1-[[6-[(1S)-1-piperidin-1-ylpropyl]-2-pyridinyl]methyl]triazol-4-yl]pyridin-2-amine;4-(3-methylphenyl)-6-[1-[[6-[(1R)-1-piperidin-1-ylpropyl]-2-pyridinyl]methyl]triazol-4-yl]pyrimidin-2-amine;(2S)-1-[6-[[4-[6-(3-methylphenyl)-2-(propan-2-ylamino)pyrimidin-4-yl]triazol-1-yl]methyl]-2-pyridinyl]pyrrolidine-2-carboxylic acid (PubChem CID 164953594) has the molecular formula C137H151N37O10 and a molecular weight of 2475.96 g/mol. Its IUPAC name is 2-[[4-[1-[(6-tert-butyl-2-pyridinyl)methyl]triazol-4-yl]-6-(3-methylphenyl)-2-pyridinyl]amino]acetic acid;bis(carbon dioxide);(2S)-1-[6-[[4-[2-(cyclopropylamino)-6-(3-methylphenyl)pyrimidin-4-yl]triazol-1-yl]methyl]-2-pyridinyl]pyrrolidine-2-carboxylic acid;6-(3-methylphenyl)-4-[1-[[6-[(1S)-1-piperidin-1-ylpropyl]-2-pyridinyl]methyl]triazol-4-yl]pyridin-2-amine;4-(3-methylphenyl)-6-[1-[[6-[(1R)-1-piperidin-1-ylpropyl]-2-pyridinyl]methyl]triazol-4-yl]pyrimidin-2-amine;(2S)-1-[6-[[4-[6-(3-methylphenyl)-2-(propan-2-ylamino)pyrimidin-4-yl]triazol-1-yl]methyl]-2-pyridinyl]pyrrolidine-2-carboxylic acid.
| Compound Name | 2-[[4-[1-[(6-tert-butyl-2-pyridinyl)methyl]triazol-4-yl]-6-(3-methylphenyl)-2-pyridinyl]amino]acetic acid;bis(carbon dioxide);(2S)-1-[6-[[4-[2-(cyclopropylamino)-6-(3-methylphenyl)pyrimidin-4-yl]triazol-1-yl]methyl]-2-pyridinyl]pyrrolidine-2-carboxylic acid;6-(3-methylphenyl)-4-[1-[[6-[(1S)-1-piperidin-1-ylpropyl]-2-pyridinyl]methyl]triazol-4-yl]pyridin-2-amine;4-(3-methylphenyl)-6-[1-[[6-[(1R)-1-piperidin-1-ylpropyl]-2-pyridinyl]methyl]triazol-4-yl]pyrimidin-2-amine;(2S)-1-[6-[[4-[6-(3-methylphenyl)-2-(propan-2-ylamino)pyrimidin-4-yl]triazol-1-yl]methyl]-2-pyridinyl]pyrrolidine-2-carboxylic acid |
|---|---|
| PubChem CID | 164953594 |
| Molecular Formula | C137H151N37O10 |
| Molecular Weight | 2475.96 g/mol |
| Exact Mass | 2474.24 |
| IUPAC Name | 2-[[4-[1-[(6-tert-butyl-2-pyridinyl)methyl]triazol-4-yl]-6-(3-methylphenyl)-2-pyridinyl]amino]acetic acid;bis(carbon dioxide);(2S)-1-[6-[[4-[2-(cyclopropylamino)-6-(3-methylphenyl)pyrimidin-4-yl]triazol-1-yl]methyl]-2-pyridinyl]pyrrolidine-2-carboxylic acid;6-(3-methylphenyl)-4-[1-[[6-[(1S)-1-piperidin-1-ylpropyl]-2-pyridinyl]methyl]triazol-4-yl]pyridin-2-amine;4-(3-methylphenyl)-6-[1-[[6-[(1R)-1-piperidin-1-ylpropyl]-2-pyridinyl]methyl]triazol-4-yl]pyrimidin-2-amine;(2S)-1-[6-[[4-[6-(3-methylphenyl)-2-(propan-2-ylamino)pyrimidin-4-yl]triazol-1-yl]methyl]-2-pyridinyl]pyrrolidine-2-carboxylic acid |
| SMILES | CC[C@@H](c1cccc(Cn2cc(-c3cc(N)nc(-c4cccc(C)c4)c3)nn2)n1)N1CCCCC1.CC[C@H](c1cccc(Cn2cc(-c3cc(-c4cccc(C)c4)nc(N)n3)nn2)n1)N1CCCCC1.Cc1cccc(-c2cc(-c3cn(Cc4cccc(C(C)(C)C)n4)nn3)cc(NCC(=O)O)n2)c1.Cc1cccc(-c2cc(-c3cn(Cc4cccc(N5CCC[C@H]5C(=O)O)n4)nn3)nc(NC(C)C)n2)c1.Cc1cccc(-c2cc(-c3cn(Cc4cccc(N5CCC[C@H]5C(=O)O)n4)nn3)nc(NC3CC3)n2)c1.O=C=O.O=C=O |
| InChI | InChI=1S/C28H33N7.C27H28N8O2.C27H30N8O2.C27H32N8.C26H28N6O2.2CO2/c1-3-27(34-13-5-4-6-14-34)24-12-8-11-23(30-24)18-35-19-26(32-33-35)22-16-25(31-28(29)17-22)21-10-7-9-20(2)15-21;1-17-5-2-6-18(13-17)21-14-22(31-27(30-21)29-19-10-11-19)23-16-34(33-32-23)15-20-7-3-9-25(28-20)35-12-4-8-24(35)26(36)37;1-17(2)28-27-30-21(19-8-4-7-18(3)13-19)14-22(31-27)23-16-34(33-32-23)15-20-9-5-11-25(29-20)35-12-6-10-24(35)26(36)37;1-3-26(34-13-5-4-6-14-34)22-12-8-11-21(29-22)17-35-18-25(32-33-35)24-16-23(30-27(28)31-24)20-10-7-9-19(2)15-20;1-17-7-5-8-18(11-17)21-12-19(13-24(29-21)27-14-25(33)34)22-16-32(31-30-22)15-20-9-6-10-23(28-20)26(2,3)4;2*2-1-3/h7-12,15-17,19,27H,3-6,13-14,18H2,1-2H3,(H2,29,31);2-3,5-7,9,13-14,16,19,24H,4,8,10-12,15H2,1H3,(H,36,37)(H,29,30,31);4-5,7-9,11,13-14,16-17,24H,6,10,12,15H2,1-3H3,(H,36,37)(H,28,30,31);7-12,15-16,18,26H,3-6,13-14,17H2,1-2H3,(H2,28,30,31);5-13,16H,14-15H2,1-4H3,(H,27,29)(H,33,34);;/t27-;2*24-;26-;;;/m0001.../s1 |
| InChIKey | AWBNUASCWSRUPH-JWRBMOAKSA-N |
| XLogP | 21.15 |
| TPSA | 602.39 Ų |
| H-Bond Donors | 8 |
| H-Bond Acceptors | 44 |
| Rotatable Bonds | 37 |
| Heavy Atoms | 184 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2475.96 |
| LogP ≤ 5 | 21.15 |
| H-Bond Donors ≤ 5 | 8 |
| H-Bond Acceptors ≤ 10 | 44 |